Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SurModics sees 16% fall in Q4 revenues
SurModics has posted a net loss of $21.66m for the fourth quarter 2010, or $1.25 loss per diluted share, compared to net income of $2.71m, or $0.16 per
SurModics has posted a net loss of $21.66m for the fourth quarter 2010, or $1.25 loss per diluted share, compared to net income of $2.71m, or $0.16 per
The Bloom-DM study evaluated obese and overweight patients with type 2 diabetes who were randomised to Lorcaserin 10mg BID, Lorcaserin 10mg dosed once daily (QD) or placebo. The
LaRosa will report to Steve Andrzejewski, CEO of Nycomed US. He will be the chief legal advisor of the company and oversee all of the company’s legal and
GSK has not been charged with a crime and was not identified in the indictment. The indictment states that in October 2002, the FDA asked for information about
Huifeng develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production As per the terms of agreement, Jucheng shall provide $3.9m
The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic and autoimmune diseases. Antigen Express said that the proprietary vaccine being
The results from this trial are expected in the second quarter of 2011 and will be used in evaluating potential further clinical development of Bafetinib in patients with
The awards were approved by the Internal Revenue Service (IRS), in conjunction with the Department of Heath and Human Services (DHHS), under the Qualifying Therapeutic Discovery Project Program.
PolyMedix has initiated a Phase 1 clinical trial in US, which is designed to further evaluate the safety and pharmacokinetic profile of PMX-30063 in female subjects, who have
Bionovo said that Menerba is an oral botanical drug candidate designed for the safe, effective treatment of vasomotor symptoms (hot flashes) associated with menopause. Bionovo president and chief